[EN] NOVEL [1,2,4]TRIAZOLO[4, 3-A]QUINOXALINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BET PROTEIN-RELATED DISEASES, CONTAINING SAME AS ACTIVE INGREDIENT<br/>[FR] NOUVEAU DÉRIVÉ DE [1,2,4]TRIAZOLO[4, 3-A]QUINOXALINE, SON PROCÉDÉ DE PRÉPARATION, ET COMPOSITION PHARMACEUTIQUE POUR LA PRÉVENTION OU LE TRAITEMENT DE MALADIES ASSOCIÉES À LA PROTÉINE BET, CONTENANT LEDIT DÉRIVÉ COMME PRINCIPE ACTIF<br/>[KO] 신규한 [1, 2, 4] 트리아졸로 [4, 3-A]퀴녹살린 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 BET 단백질 관련 질환의 예방 또는 치료용 약학적 조성물
申请人:DONG WHA PHARM CO LTD
公开号:WO2018139876A1
公开(公告)日:2018-08-02
신규한 [1, 2, 4]트리아졸로[4, 3-a]퀴녹살린 유도체, 이들의 제조방법 및 이를 유효성분으로 함유하는 암 및 자가면역질환을 포함한 BET(Bromodomain Extra-terminal) 단백질 관련 질환의 예방 또는 치료용 약학적 조성물이 제공된다.
Carbon Dioxide-Mediated C(sp<sup>3</sup>)–H Arylation of Amine Substrates
作者:Mohit Kapoor、Daniel Liu、Michael C. Young
DOI:10.1021/jacs.8b05061
日期:2018.6.6
Elaborating amines via C-H functionalization has been an important area of research over the past decade but has generally relied on an added directing group or sterically hindered amine approach. Since free-amine-directed C(sp3)-H activation is still primarily limited to cyclization reactions and to improve the sustainability and reaction scope of amine-based C-H activation, we present a strategy